Using flavoxate as primary medication for patients suffering from urge symptomatology.

Author: BlessmanG, Fehrmann-ZumpeP, KarbeK

Paper Details 
Original Abstract of the Article :
A drug utilization observation study collected data on a total of 1800 patients given flavoxate (Spasuret 200) over 2 weeks for urge incontinence. Efficacy and tolerance parameters were determined. A subgroup of 618 patients without urinary tract infections or benign prostatic hyperplasia were treat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/pl00004018

データ提供:米国国立医学図書館(NLM)

Flavoxate: A Potential Solution for Urge Incontinence

The field of urology often seeks to address the challenges of urinary incontinence, a common issue with significant impact on quality of life. This study investigates the efficacy and tolerability of flavoxate, a medication frequently employed in the management of urge incontinence. The researchers conducted a drug utilization observation study to assess the effectiveness of flavoxate in a large cohort of patients.

Flavoxate Shows Promise in Managing Urge Incontinence

The study demonstrated a significant reduction in dysuria, nocturia, and both daytime and nighttime urge in patients treated with flavoxate. The medication also resulted in a notable increase in bladder volume at first urge sensation. These findings suggest that flavoxate is a potentially valuable tool in managing urge incontinence, offering relief to those experiencing this debilitating condition.

A Hopeful Outlook for Urinary Incontinence Treatment

This research provides a glimmer of hope for individuals seeking effective treatments for urge incontinence. The study indicates that flavoxate can be a viable option for managing symptoms, potentially leading to a better quality of life for patients. While individual responses to medication can vary, the encouraging results of this study warrant further investigation and consideration of flavoxate as a potential therapeutic approach.

Dr. Camel's Conclusion

Just as a camel navigates the arid landscapes of the desert, this research helps navigate the complex terrain of urinary incontinence. The study offers a promising solution with flavoxate, a medication demonstrating potential for improved bladder control and a better quality of life for patients. Like a well-stocked oasis, this research provides a source of hope for those seeking relief from this common and often embarrassing condition.

Date :
  1. Date Completed 1999-07-29
  2. Date Revised 2019-11-03
Further Info :

Pubmed ID

10384969

DOI: Digital Object Identifier

10.1007/pl00004018

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.